New Hope for Delayed Sleep-Wake Phase Disorder Vanda Pharmaceuticals has reached a significant milestone in sleep medicine. The company recently announced positive results from its Phase III clinical trial evaluating Hetlioz (tasimelteon) for the treatment of Delayed Sleep-Wake Phase Disorder (DSWPD). Understanding DSWPD Delayed Sleep-Wake Phase Disorder is a chronic circadian rhythm disorder characterized by…